Thursday 4th November 2021

First take at home COVID-19 antiviral treatments approved for vulnerable adults

Yesterday, the UK’s Medicine and Health products Regulation Agency approved the world’s first ‘take at home’ COVID-19 treatment, Lagevrio – one of two antiviral treatments secured by the UK Government in October.

Read Article

Wednesday 27th November 2019

Nutrition and exercise for chronic conditions

Many things can impact the quality of a person’s life, especially if you are living with a long-term chronic condition like scleroderma or Raynaud’s phenomenon. There are many ways to help manage the conditions, including better nutrition and exercise.

Read Article

Thursday 21st November 2019

Early Detection: A history of funding from SRUK

SRUK has long recognised that detecting the conditions earlier is key to ensuring that people live longer and better lives, which is why we fund studies to improve our understanding of the early warning signs of the conditions.

Read Article

Tuesday 19th November 2019

Quality of Life: A history of funding from SRUK

Here, we highlight some examples of research projects that have been funded by SRUK in the past which focus on improving quality of life for patients.

Read Article

Tuesday 5th November 2019

Research into gut involvement in systemic sclerosis

Dr Tracey Frech, the director of the systemic sclerosis (SSc) clinic at the University of Utah, and Salt Lake Veterans Affair Medical Centre, focussed her talk at the Cambridge conference on gut involvement in systemic sclerosis and the importance of research in this subject area.

Read Article

Friday 30th November 2018

Enhanced Liver Fibrosis Test: A new biomarker of fibrosis in systemic sclerosis

A multicentre study spread across Europe was recently conducted to evaluate how effective the Enhanced Liver Fibrosis (ELF) Test would be as a biomarker of fibrosis (scarring) in systemic sclerosis (SSc).This would aid the understanding of what drives fibrosis in individuals and thus enable the application of precision medicine for treatment strategies.

Read Article

Thursday 8th November 2018

Is gastroesophageal reflux contributing to lung scarring?

A research collaboration between the Royal Free and Royal Brompton hospitals, funded by Scleroderma and Raynaud’s UK (SRUK), is investigating if reflux from the stomach into the oesophagus plays a role in lung scarring in scleroderma patients.

Read Article

Tuesday 6th November 2018

Is there a link between Localised and Systemic Scleroderma?

Keloid morphea is a rare, and hence poorly understood, form of localised scleroderma that only affects the skin. A new study into the condition has the potential to make a huge beneficial impact on our community.

Read Article

Friday 2nd November 2018

Alternative Therapies: Do they help Raynaud’s?

Over the years, many people living with Raynaud’s have advocated for the use of Chinese acupuncture and Chinese acupressure, but do they actually help?

Read Article

Wednesday 8th November 2017

Research into best practice for capillaroscopy

Research study into the number of fingers which should be examined during a capillaroscopy to identify scleroderma.

Read Article